Now Live: Cboe Europe real-time data for all major European stocks.
8.13000 USD
2.97
26.76%
Last update Feb 27, 3:59 PM EST
Market closed
Day range
8
9.57000
Previous close
11.10000
Open
8.20000
Access this stock data via API
Subscribe
Emergent BioSolutions Inc.
8.13
2.97
26.76%

Financials

Income statement

Fiscal date 2024 2023 2022 2021
Total reported revenue 1.0B 1.0B 1.1B 1.6B
Cost of revenue 681.3M 705.4M 693.1M 748.1M
Gross profit 332.3M 317.6M 383M 891.3M
Operating expense
Research & development 70.7M 111.4M 188.3M 235.2M
Selling general and admin 308M 368.4M 339.5M 348.7M
Other operating expenses -30M -26.3M -41.4M -134.2M
Operating income -81.5M -201.5M -163.3M 383.1M
Non operating interest income
Income
Expense 71M 87.9M 37.3M 34.5M
Other income expense 9.6M -441.8M -18.4M -45.4M
Pretax income -142.9M -731.2M -219M 303.2M
Tax provision 47.7M 29.3M -7.4M 83.7M
Net income -190.6M -760.5M -211.6M 219.5M
Basic EPS -3.6 -14.9 -4.5 4.3
Diluted EPS -3.6 -14.9 -4.5 4.3
Basic average shares 53M 51.2M 50.1M 53.5M
Diluted average shares 53M 51.2M 50.1M 53.5M
EBITDA 39.8M -67.5M -31.7M 503.2M
Net income from continuing op. -190.6M -760.5M -211.6M 219.5M
Minority interests
Preferred stock dividends
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Market closed

Exchange is currently closed
Pre-market opens in 2 days 7 hours 2 minutes

20:57
00:00
09:30
16:00
23:59

Trading Hours (Monday - Friday):

Pre-market
04:00 - 09:30
Main market
09:30 - 16:00
Post-market
16:00 - 20:00
All times are displayed in the America/New_York timezone (EST, UTC-05:00).